Serum levels of the cytokines IL-1β, IL-6 and ICAM-1 after 131I-treatment of Graves' disease and nodular goiter

Hormone and Metabolic Research

Volumn 32, Issue 7, 2000, Pages 283-287

  Nygaard, B ^a   Jarlov, A E ^b   Kristensen, L O ^a   Faber, J ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

Goiter; Hyperthyroidism; ICAM 1; Interleukin 1; Interleukin 6; Radioiodine

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; IODINE 131; THYROGLOBULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IODINATION; MALE; NODULAR GOITER; PRIORITY JOURNAL;

EID: 0033836309     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978637     Document Type: Article

References (20)

1. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins
2. 131I-treatment in patients with non-toxic goiter
3. 131I therapy
4. Autoimmune thyroiditis: Predisposition and pathogenesis
5. 131I-treatment for hyperthyroidism
6. Serum levels of interleukin 6 and tumor necrosis factor-α in hyperthyroid patients before and after propylthiouracil treatment
7. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
8. A prospective study of the differential changes in serum thyroglobulin and its autoantibodies during propylthiouracil or radioiodine therapy of patients with Graves' disease
9. Subtle changes in serum thyrotrophin (TSH) and sex-hormone-binding globulin (SHBG) levels during long-term follow-up after radioactive iodine in multinodular non-toxic goitre
10. 131I therapy of multinodular goiter
11. Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease
12. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters
13. The transition of subacute thyroiditis to Graves' disease as evidenced by diagnostic imaging
14. Graves' disease occurring after subacute thyroiditis: Report of a case and review of the literature
15. Appearance of Graves' disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma
16. Graves' disease after percutaneous ethanol injection for the treatment of autonomous thyroid adenoma
17. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy
18. Interleukin-6: A marker of thyroid-destructive processes?
19. Human soluble IL-6 receptor: Its detection and enhanced release by HIV infection
20. Increased serum interleukin-6 concentration in patients with subacute thyroiditis: Relationship with concomitant changes I serum T4-binding globulin concentration